THE CONFERENCE HAS BEEN POSTPONED TO
7 - 9 MARCH 2008.
PLEASE CLICK HERE FOR FURTHER INFORMATION.
THE PROGRAMME IS IN PREPARATION
BACKGROUND AND SCOPE
Current estimates suggest that over 11 million people are diagnosed with cancer globally and sadly over 8 million die from cancer-related causes annually.
The European School of Oncology (ESO) has had a significant commitment over the past two decades in contributing towards an improved cancer care, ranging from preventive and
screening measures to the education of the cancer care team in general. The ESO Global Insight Conference should add a further dimension by focusing on specific cancers in multiple geographic locations to develop a good infrastructure for improving patients' outcomes through
The inaugural programme for this series should address adult and childhood leukaemias, an area in which significant advances in many aspects, including molecular understanding, better diagnostic and risk stratifications, classifications and therapies, in particular molecularly targeted therapies. Leukaemias, in particular chronic myeloid leukaemia, promises to revolutionize the treatments of cancers in general and the lessons learned have resulted in the successful application of targeted therapies for many common cancers. Supportive and adjunctive therapies have also improved and the local applicability of such treatments will also
Scientists, adult and paediatric haematologists, oncologists, pathologists and other members of the health discipline involved in the care of patients with leukaemias.
European School of Oncology - Bellinzona Office
Oncology Institute of Southern Switzerland
Ospedale Reg. Bellinzona e Valli
CH-6500 Bellinzona, Switzerland
Tel: +41 91 811 8050 - Fax: +41 91 811 8051